← National Association of Chain Drug Stores
FDARulemakingFDA-2015-N-0030

Compounding of Human Drug Products Under Sections 503A and 503B of the Federal Food, Drug, and Cosmetic Act; Establishment of a Public Docket

RIN
—
Last modified
May 18, 2026
Comment window
closed 1442d ago
National Association of Chain Drug Stores filings
1

Activity

National Association of Chain Drug Stores filed 1 comment on this docket between Aug 10, 2017 and Aug 10, 2017. 27 other organizations filed here. The comment window closed 1442d ago.

What National Association of Chain Drug Stores filed (1)

Aug 10, 2017· Comment from National Association of Chain Drug Stores (NACDS)· FDA-2015-N-0030-0319

The National Association of Chain Drug Stores (NACDS) is submitting the attached comments to the Food and Drug Administration (FDA) to follow-up on several issues related to the discussion at the June 5, 2017 listening session on implementation of the compounding provisions of the Drug Quality and Security Act (DQSA). We thank FDA for considering our further input on these matters.

View on regulations.gov →

Abstract

Compounding of Human Drug Products

View on regulations.gov →

Co-filers (27)

See everyone who commented →
Compounding of Human Drug Products Under Sections 503A and 503B of the Federal Food, Drug, and Cosmetic Act; Establishment of a Public Docket (FDA) — National Association of Chain Drug Stores | OpenPolis